Company profile for HavaH Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HavaH Therapeutics is developing androgen therapies for breast disease by utilizing the innate breast-tissue-specific hormone/immune interface. HavaH Therapeutics lead product delivers a unique androgen product to effect a beneficial tissue specific alteration in estrogen: androgen ratio and reduce breast tissue autoimmune inflammation. HavaH Therapeutics is dedicated to developing androgenic products for women, initially t...
HavaH Therapeutics is developing androgen therapies for breast disease by utilizing the innate breast-tissue-specific hormone/immune interface. HavaH Therapeutics lead product delivers a unique androgen product to effect a beneficial tissue specific alteration in estrogen: androgen ratio and reduce breast tissue autoimmune inflammation. HavaH Therapeutics is dedicated to developing androgenic products for women, initially targeting rare breast disease where autoimmunity is the underlying mechanism of the pathogenesis e.g. granulomatous and peri-ductal mastitis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
10-20 New Street North Adelaide, South Australia 5006
Telephone
Telephone
+61 8 7200 5606
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250326184041/en/Havah-Therapeutics-Announces-the-Filing-of-a-Patent-Application-Relating-to-the-Use-of-HAV-088-for-Reducing-Tumor-Size-and-Conserving-Breast-Tissue

BUSINESSWIRE
27 Mar 2025

https://www.businesswire.com/news/home/20241030240005/en

BUSINESSWIRE
30 Oct 2024

https://www.businesswire.com/news/home/20241024530825/en

BUSINESSWIRE
24 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty